STAR COMBO PHARMA LIMITED — Major Shareholding Notification 2018

Aug 14, 2018

Form 603

Corporations Act 2001 Section 671B

Notice of initial substantial holder

. $\sim$ 3.9 To Company Name/Scheme .	セヘー	Combo		Pharma Limited
Contract Contract ACN/ARSN
the contract of the contract of	CONTRACTOR

		1. Details of substantial holder (1)

Name		Medical CEUMORD Cooperatief
ACN/ARSN (if applicable)
		All Angels . Contract Contract Contract .
The holder became a substantial holder on	.

1. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a
| relevant interest (3) in on the date the substantial hold

Class of securities (4)	Number of securities	Person's votes (5)	Voting power (6)
ardiman.

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest	Nature of relevant interest (7)	Class and number of securities
Leou Medical (Europe)		Eillypaiderdingsheres
Cooperation U.A.		$\sim$ 00, 000

1. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant interest	Registered holder of securities	Person entitled to be registered as holder (8)	Class and number of securities
	Leou Medical (Eurod) Legu Medical (Europe)
cooperation. $\mathbf{U} \cdot \mathbf{A}$	Cooperatiof u.A.		$0,000,000$ .

5. Consideration

.
The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a
substantial holder is as follows:

Holder of relevant interest	Date of acquisition	Consideration (9)		Class and number of securities
		Cash	Non-cash

page 2/2 15 July 2001 603

K. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
	. والمتحامين المتعدد ومعطوفه وخضراف المتعادلا فستحتذ والمددد

7. Addresses

The addresses of persons named in this form are as follows:

Name	\ddress
CEU. ndical	$1 - n +$ Lanctra Boulevard 4501
	しべっぱく A

Signature

		lirentor.
Service		date $1410812018$
the company of the company of	and the state All College and the control .	Contract Contract the contract of the con- the state of the con- The contract of the contract of the contract of Contract Contract Contract the contract of the contract of the .

DIRECTIONS

• If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an $\langle 0 \rangle$ in these are a number of advanced to an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to the form interests of a group of persons are essentially simila form.
• See the definition of "associate" in section 9 of the Corporations Act 2001. $(2)$
• See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001. $\langle 0 \rangle$
• The voting shares of a company constitute one class unless divided into separate classes. $(4)$
• The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant $(5)$ Interest in.
• The person's votes divided by the total votes in the body corporate or scheme multiplied by 100. $(6)$

$\sqrt{a}$ Include details of:

• any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 6718(4) applies, a copy of any document setting out
  the terms of any relevant agreement, and a statement by the perso ${a}$
• any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to
  which the relevant interest relates (indicating clearly the ${0}$

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown". $(8)$
• Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become $(9)$ entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the subst the relevant interest was acquired.

GUIDE This guide does not form part of the prescribed form
and is included by ASIC to assist you in completing
and lodging form 603.

Signature	This form must be signed by either a director or a secretary of the substantial holder.
Lodging period	Nil
LodgingFee	Nil
Otherformstobe	Nil
completed
Additionalinformation
	(a) If additional space is required to complete a question, the information may be included on a separate piece of paper annexed to the form,
	(b) This notice must be given to a listed company, or the responsible entity for a listed managed investment
	scheme. A copy of this notice must also be given to each relevant securities exchange.
	(c) The person must give a copy of this notice:
	(i) within 2 business days after they become aware of the information; or
	(ii) by 9.30 am on the next trading day of the relevant securities exchange after they become aware of the
	information if:
	(A) a takeover bid is made for voting shares in the company or voting interests in the scheme; and
	(B) the person becomes aware of the information during the bid period.
Annexures
	To make any annexure conform to the regulations, you must
	1 use A4 size paper of white or light pastel colour with a margin of at least 10mm on all sides 2 show the corporation name and ACN or ARBN
	3 number the pages consecutively
	4 print or type in BLOCK letters in dark blue or black ink so that the document is clearly legible when
	photocopied
	5 identify the annexure with a mark such as $A$ , $B$ , $C$ , etc.
	6 endorse the annexure with the words:
	This is annexure (mark) of (number) pages referred to in form (form numbersand title)
	7 sign and date the annexure The annexure must be signed by the same person(s) who signed the form.